01.11.2006
Oral Administration of Imatinib to P230 BCR/ABL-Expressing Transgenic Mice Changes Clones with High BCR/ABL Complementary DNA Expression into Those with Low Expression
Erschienen in: International Journal of Hematology | Ausgabe 4/2006
Einloggen, um Zugang zu erhalten